| Analysis | Metabolite Name | Measured Value | Units | level of dysplasia | malignant transformation |
|---|---|---|---|---|---|
| Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 2877 | Peak area | LGD | No |
| Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 5054 | Peak area | N/A | No |
| Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 6910 | Peak area | LGD | No |
| Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 14883 | Peak area | HGD & PDA | yes |
| Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 15206 | Peak area | N/A | No |
| Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 17577 | Peak area | LGD | No |
| Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 31503 | Peak area | N/A | No |
| Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | Peak area | HGD | No | |
| Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | Peak area | HGD & PDA | Yes | |
| Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | Peak area | LGD | No | |
| Reversed phase POSITIVE ION MODE | GLUTAMINE (M+NA)+ | 8113 | Peak area | LGD | No |
| Reversed phase POSITIVE ION MODE | GLUTAMINE (M+NA)+ | 24691 | Peak area | N/A | No |
| Reversed phase POSITIVE ION MODE | GLUTAMINE (M+NA)+ | 43679 | Peak area | N/A | No |
| Reversed phase POSITIVE ION MODE | GLUTAMINE (M+NA)+ | Peak area | HGD | No | |
| Reversed phase POSITIVE ION MODE | GLUTAMINE (M+NA)+ | Peak area | HGD & PDA | yes | |
| Reversed phase POSITIVE ION MODE | GLUTAMINE (M+NA)+ | Peak area | HGD & PDA | Yes | |
| Reversed phase POSITIVE ION MODE | GLUTAMINE (M+NA)+ | Peak area | LGD | No | |
| Reversed phase POSITIVE ION MODE | GLUTAMINE (M+NA)+ | Peak area | N/A | No |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|